Skip to main content

Statistical methods for clinical studies in the presence of surrogate end points

Buy Article:

$51.00 plus tax (Refund Policy)

The use of surrogate end points has become increasingly common in medical and biological research. This is primarily because, in many studies, the primary end point of interest is too expensive or too difficult to obtain. There is now a large volume of statistical methods for analysing studies with surrogate end point data. However, to our knowledge, there has not been a comprehensive review of these methods to date. This paper reviews some existing methods and summarizes the strengths and weaknesses of each method. It also discusses the assumptions that are made by each method and critiques how likely these assumptions are met in practice.
No References
No Citations
No Supplementary Data
No Data/Media
No Metrics

Keywords: Auxiliary information; Censoring; Coarsening; Markov process; Missing values

Document Type: Original Article

Affiliations: Memorial Sloan–Kettering Cancer Center, New York, USA, and Singapore Management University, Singapore

Publication date: 2001-01-01

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more